Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-12

AUTHORS

Amalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, Jamboor K Vishwanatha

ABSTRACT

BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process. METHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out. RESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5±9.8 nm and the drug loading was determined to be 10.32±1.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-∞) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation. CONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch. More... »

PAGES

38

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1477-3155-10-38

DOI

http://dx.doi.org/10.1186/1477-3155-10-38

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014874253

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22937885


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Curcumin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Carriers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Stability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microscopy, Confocal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Chemical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Particle Size", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyglycolic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription Factor RelA", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ranjan", 
        "givenName": "Amalendu P", 
        "id": "sg:person.0702554625.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702554625.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mukerjee", 
        "givenName": "Anindita", 
        "id": "sg:person.01203736343.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203736343.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "SignPath Pharmaceuticals Inc, Quakertown, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Helson", 
        "givenName": "Lawrence", 
        "id": "sg:person.0671324400.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671324400.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vishwanatha", 
        "givenName": "Jamboor K", 
        "id": "sg:person.0747516710.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747516710.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1211/0022357056145", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000190052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.795", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000384874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2009.04.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001694367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/29/295104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004077122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0945-053x(02)00007-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004622721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-010-9907-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004700764", 
          "https://doi.org/10.1007/s11051-010-9907-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-010-9907-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004700764", 
          "https://doi.org/10.1007/s11051-010-9907-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.addr.2006.09.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004829869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(03)00048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004891465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(03)00048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004891465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2009.06.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005624862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-04-0744", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005777798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.phymed.2009.04.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007104432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-3659(02)00127-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016356395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/4/045101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016473251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/4/045101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016473251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2005.12.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019030001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10856-006-8940-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019759297", 
          "https://doi.org/10.1007/s10856-006-8940-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-5173(96)04854-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019942185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2009.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021088722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-3155-5-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022264103", 
          "https://doi.org/10.1186/1477-3155-5-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-1957", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022589290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biomaterials.2010.04.062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022925716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2008.08.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024533252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0278-6915(02)00258-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025649519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0278-6915(02)00258-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025649519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.seppur.2007.09.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025778528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2010.08.033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026393875"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2006.12.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027033711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drudis.2011.09.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030898701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2011.07.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032707596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2007.09.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034318659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp700113r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034955222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp700113r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034955222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2010.03.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037770056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/cpb.54.977", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039457151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(01)00095-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041280693"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1211/jpp.61.03.0005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044389552"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tips.2009.04.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046996104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ijn.s17386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047104794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejps.2009.02.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049067143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639045.2011.563781", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049089983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.powtec.2009.09.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051563586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.1244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051768727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.1244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051768727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2006.09.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053212930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1214/aoms/1177707047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064401263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/092986710790149738", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069161671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/138920012798356952", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069176048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074955168", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1211/jpp/61.03.0005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077850891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077974252", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00224065.1980.11980968", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101183642"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-12", 
    "datePublishedReg": "2012-12-01", 
    "description": "BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process.\nMETHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out.\nRESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5\u00b19.8 nm and the drug loading was determined to be 10.32\u00b11.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-\u221e) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation.\nCONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1477-3155-10-38", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7821992", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1031280", 
        "issn": [
          "1477-3155"
        ], 
        "name": "Journal of Nanobiotechnology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy", 
    "pagination": "38", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "46ddcf245630edb02dcc6fc00efd450de7a74ee330b538a825b6df36d6b0ab84"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22937885"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101152208"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1477-3155-10-38"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014874253"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1477-3155-10-38", 
      "https://app.dimensions.ai/details/publication/pub.1014874253"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000549.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1477-3155-10-38"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'


 

This table displays all metadata directly associated to this object as RDF triples.

307 TRIPLES      21 PREDICATES      94 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1477-3155-10-38 schema:about N03bb0d44cb3c46918dbe7835cf566ce9
2 N05170fbdce874b86911f9999ff715d9f
3 N06d56f22a8b44209ba59b831ad6d7dab
4 N1f578819da5746b2af3bccde7f6e3604
5 N26ea5bfcdff640f1b21f76e9b8f31156
6 N29a9753863b64f889e6103960b2f0fb9
7 N376e7ca2957b4d97af875845a6aa29f4
8 N595a590bc00d427dadafc5dfabc23f07
9 N683075ecff42411c9a8389bdbc638e81
10 N6d75e2525023455aa90429005743e344
11 N71980ed27f9049fca1a5e388a570804a
12 N7b840a43bc0245cea846464a9fbb2c4c
13 N7e62312d5334407e8963b2af228a814a
14 N93f52402914a4102ac935ad7d0371637
15 Nbacc8bd23cd549ecb832edf54ec6e4af
16 Nd8a04a129ae14c6c8b9451d0b461edef
17 Nf58c455e2d694768854e2e6149840cb4
18 Nfc68689a09bc4301af36d4914348d64d
19 anzsrc-for:03
20 anzsrc-for:0306
21 schema:author Ncccd3a27df1041568c2da965186a5fb0
22 schema:citation sg:pub.10.1007/s10856-006-8940-4
23 sg:pub.10.1007/s11051-010-9907-4
24 sg:pub.10.1186/1477-3155-5-3
25 https://app.dimensions.ai/details/publication/pub.1074955168
26 https://app.dimensions.ai/details/publication/pub.1077974252
27 https://doi.org/10.1002/bmc.1244
28 https://doi.org/10.1002/bmc.795
29 https://doi.org/10.1016/j.addr.2006.09.017
30 https://doi.org/10.1016/j.biomaterials.2010.04.062
31 https://doi.org/10.1016/j.drudis.2011.09.009
32 https://doi.org/10.1016/j.ejpb.2007.09.009
33 https://doi.org/10.1016/j.ejpb.2009.02.002
34 https://doi.org/10.1016/j.ejpb.2009.06.002
35 https://doi.org/10.1016/j.ejps.2009.02.019
36 https://doi.org/10.1016/j.ijpharm.2005.12.013
37 https://doi.org/10.1016/j.ijpharm.2006.09.025
38 https://doi.org/10.1016/j.ijpharm.2006.12.043
39 https://doi.org/10.1016/j.ijpharm.2008.08.009
40 https://doi.org/10.1016/j.ijpharm.2009.04.045
41 https://doi.org/10.1016/j.ijpharm.2010.03.034
42 https://doi.org/10.1016/j.ijpharm.2010.08.033
43 https://doi.org/10.1016/j.nano.2011.07.011
44 https://doi.org/10.1016/j.phymed.2009.04.008
45 https://doi.org/10.1016/j.powtec.2009.09.004
46 https://doi.org/10.1016/j.seppur.2007.09.005
47 https://doi.org/10.1016/j.tips.2009.04.005
48 https://doi.org/10.1016/s0168-3659(02)00127-x
49 https://doi.org/10.1016/s0278-6915(02)00258-2
50 https://doi.org/10.1016/s0378-5173(96)04854-5
51 https://doi.org/10.1016/s0928-0987(01)00095-1
52 https://doi.org/10.1016/s0928-0987(03)00048-4
53 https://doi.org/10.1016/s0945-053x(02)00007-0
54 https://doi.org/10.1021/mp700113r
55 https://doi.org/10.1080/00224065.1980.11980968
56 https://doi.org/10.1088/0957-4484/22/29/295104
57 https://doi.org/10.1088/0957-4484/22/4/045101
58 https://doi.org/10.1158/1078-0432.ccr-04-0744
59 https://doi.org/10.1158/1078-0432.ccr-08-1957
60 https://doi.org/10.1211/0022357056145
61 https://doi.org/10.1211/jpp.61.03.0005
62 https://doi.org/10.1211/jpp/61.03.0005
63 https://doi.org/10.1214/aoms/1177707047
64 https://doi.org/10.1248/cpb.54.977
65 https://doi.org/10.2147/ijn.s17386
66 https://doi.org/10.2174/092986710790149738
67 https://doi.org/10.2174/138920012798356952
68 https://doi.org/10.3109/03639045.2011.563781
69 schema:datePublished 2012-12
70 schema:datePublishedReg 2012-12-01
71 schema:description BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process. METHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out. RESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5±9.8 nm and the drug loading was determined to be 10.32±1.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-∞) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation. CONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch.
72 schema:genre research_article
73 schema:inLanguage en
74 schema:isAccessibleForFree true
75 schema:isPartOf N61a09ef205aa403d8cc9470e54708f9a
76 Na716482af55d4fc9a8127aae29229d66
77 sg:journal.1031280
78 schema:name Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy
79 schema:pagination 38
80 schema:productId N394c3ea7692c4297a80650916f080364
81 N6fe8be0011e34d6f92edcdcfb77669cb
82 N9f080ef0cfb94e4d82f96b3e147a4e6d
83 Nef95f1c109fd4e64b7e4c66d475da457
84 Nfe12b635c465432eb4f3cf29c3c4462c
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014874253
86 https://doi.org/10.1186/1477-3155-10-38
87 schema:sdDatePublished 2019-04-10T15:58
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher Nd374b11939874d8f93d3dbf7daefd9ea
90 schema:url http://link.springer.com/10.1186%2F1477-3155-10-38
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N03bb0d44cb3c46918dbe7835cf566ce9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Nanoparticles
96 rdf:type schema:DefinedTerm
97 N05170fbdce874b86911f9999ff715d9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Curcumin
99 rdf:type schema:DefinedTerm
100 N06d56f22a8b44209ba59b831ad6d7dab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Humans
102 rdf:type schema:DefinedTerm
103 N0fb834f42b354f64a99285774534eca4 rdf:first sg:person.0671324400.35
104 rdf:rest Ndab901a4de3a400f8c055365835b747e
105 N1f578819da5746b2af3bccde7f6e3604 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Male
107 rdf:type schema:DefinedTerm
108 N26ea5bfcdff640f1b21f76e9b8f31156 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Rats, Sprague-Dawley
110 rdf:type schema:DefinedTerm
111 N29a9753863b64f889e6103960b2f0fb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Particle Size
113 rdf:type schema:DefinedTerm
114 N376e7ca2957b4d97af875845a6aa29f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Rats
116 rdf:type schema:DefinedTerm
117 N394c3ea7692c4297a80650916f080364 schema:name pubmed_id
118 schema:value 22937885
119 rdf:type schema:PropertyValue
120 N595a590bc00d427dadafc5dfabc23f07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Research Design
122 rdf:type schema:DefinedTerm
123 N61a09ef205aa403d8cc9470e54708f9a schema:volumeNumber 10
124 rdf:type schema:PublicationVolume
125 N683075ecff42411c9a8389bdbc638e81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Antineoplastic Agents
127 rdf:type schema:DefinedTerm
128 N6d75e2525023455aa90429005743e344 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Microscopy, Confocal
130 rdf:type schema:DefinedTerm
131 N6fe8be0011e34d6f92edcdcfb77669cb schema:name dimensions_id
132 schema:value pub.1014874253
133 rdf:type schema:PropertyValue
134 N71980ed27f9049fca1a5e388a570804a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Animals
136 rdf:type schema:DefinedTerm
137 N7b840a43bc0245cea846464a9fbb2c4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Cell Line, Tumor
139 rdf:type schema:DefinedTerm
140 N7e62312d5334407e8963b2af228a814a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Models, Chemical
142 rdf:type schema:DefinedTerm
143 N93f52402914a4102ac935ad7d0371637 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Lactic Acid
145 rdf:type schema:DefinedTerm
146 N97c94ebc9029466da49eb498677f6ca1 rdf:first sg:person.01203736343.38
147 rdf:rest N0fb834f42b354f64a99285774534eca4
148 N9f080ef0cfb94e4d82f96b3e147a4e6d schema:name doi
149 schema:value 10.1186/1477-3155-10-38
150 rdf:type schema:PropertyValue
151 Na716482af55d4fc9a8127aae29229d66 schema:issueNumber 1
152 rdf:type schema:PublicationIssue
153 Nb3938af7a30a4ffb92b8a81609e74a24 schema:name SignPath Pharmaceuticals Inc, Quakertown, PA, USA
154 rdf:type schema:Organization
155 Nbacc8bd23cd549ecb832edf54ec6e4af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Polyglycolic Acid
157 rdf:type schema:DefinedTerm
158 Ncccd3a27df1041568c2da965186a5fb0 rdf:first sg:person.0702554625.45
159 rdf:rest N97c94ebc9029466da49eb498677f6ca1
160 Nd374b11939874d8f93d3dbf7daefd9ea schema:name Springer Nature - SN SciGraph project
161 rdf:type schema:Organization
162 Nd8a04a129ae14c6c8b9451d0b461edef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Drug Carriers
164 rdf:type schema:DefinedTerm
165 Ndab901a4de3a400f8c055365835b747e rdf:first sg:person.0747516710.37
166 rdf:rest rdf:nil
167 Nef95f1c109fd4e64b7e4c66d475da457 schema:name readcube_id
168 schema:value 46ddcf245630edb02dcc6fc00efd450de7a74ee330b538a825b6df36d6b0ab84
169 rdf:type schema:PropertyValue
170 Nf58c455e2d694768854e2e6149840cb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Transcription Factor RelA
172 rdf:type schema:DefinedTerm
173 Nfc68689a09bc4301af36d4914348d64d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Drug Stability
175 rdf:type schema:DefinedTerm
176 Nfe12b635c465432eb4f3cf29c3c4462c schema:name nlm_unique_id
177 schema:value 101152208
178 rdf:type schema:PropertyValue
179 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
180 schema:name Chemical Sciences
181 rdf:type schema:DefinedTerm
182 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
183 schema:name Physical Chemistry (incl. Structural)
184 rdf:type schema:DefinedTerm
185 sg:grant.7821992 http://pending.schema.org/fundedItem sg:pub.10.1186/1477-3155-10-38
186 rdf:type schema:MonetaryGrant
187 sg:journal.1031280 schema:issn 1477-3155
188 schema:name Journal of Nanobiotechnology
189 rdf:type schema:Periodical
190 sg:person.01203736343.38 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
191 schema:familyName Mukerjee
192 schema:givenName Anindita
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203736343.38
194 rdf:type schema:Person
195 sg:person.0671324400.35 schema:affiliation Nb3938af7a30a4ffb92b8a81609e74a24
196 schema:familyName Helson
197 schema:givenName Lawrence
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671324400.35
199 rdf:type schema:Person
200 sg:person.0702554625.45 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
201 schema:familyName Ranjan
202 schema:givenName Amalendu P
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702554625.45
204 rdf:type schema:Person
205 sg:person.0747516710.37 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
206 schema:familyName Vishwanatha
207 schema:givenName Jamboor K
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747516710.37
209 rdf:type schema:Person
210 sg:pub.10.1007/s10856-006-8940-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019759297
211 https://doi.org/10.1007/s10856-006-8940-4
212 rdf:type schema:CreativeWork
213 sg:pub.10.1007/s11051-010-9907-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004700764
214 https://doi.org/10.1007/s11051-010-9907-4
215 rdf:type schema:CreativeWork
216 sg:pub.10.1186/1477-3155-5-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022264103
217 https://doi.org/10.1186/1477-3155-5-3
218 rdf:type schema:CreativeWork
219 https://app.dimensions.ai/details/publication/pub.1074955168 schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1077974252 schema:CreativeWork
221 https://doi.org/10.1002/bmc.1244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051768727
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1002/bmc.795 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000384874
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/j.addr.2006.09.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004829869
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/j.biomaterials.2010.04.062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022925716
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/j.drudis.2011.09.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030898701
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/j.ejpb.2007.09.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034318659
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.ejpb.2009.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021088722
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/j.ejpb.2009.06.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005624862
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/j.ejps.2009.02.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049067143
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/j.ijpharm.2005.12.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019030001
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/j.ijpharm.2006.09.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053212930
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/j.ijpharm.2006.12.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027033711
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/j.ijpharm.2008.08.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024533252
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1016/j.ijpharm.2009.04.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001694367
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/j.ijpharm.2010.03.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037770056
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1016/j.ijpharm.2010.08.033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026393875
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.nano.2011.07.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032707596
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/j.phymed.2009.04.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007104432
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/j.powtec.2009.09.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051563586
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/j.seppur.2007.09.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025778528
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/j.tips.2009.04.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046996104
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/s0168-3659(02)00127-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016356395
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1016/s0278-6915(02)00258-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025649519
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1016/s0378-5173(96)04854-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019942185
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1016/s0928-0987(01)00095-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041280693
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1016/s0928-0987(03)00048-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004891465
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1016/s0945-053x(02)00007-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004622721
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1021/mp700113r schema:sameAs https://app.dimensions.ai/details/publication/pub.1034955222
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1080/00224065.1980.11980968 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101183642
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1088/0957-4484/22/29/295104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004077122
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1088/0957-4484/22/4/045101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016473251
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1158/1078-0432.ccr-04-0744 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005777798
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1158/1078-0432.ccr-08-1957 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022589290
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1211/0022357056145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000190052
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1211/jpp.61.03.0005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044389552
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1211/jpp/61.03.0005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077850891
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1214/aoms/1177707047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064401263
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1248/cpb.54.977 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039457151
296 rdf:type schema:CreativeWork
297 https://doi.org/10.2147/ijn.s17386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047104794
298 rdf:type schema:CreativeWork
299 https://doi.org/10.2174/092986710790149738 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069161671
300 rdf:type schema:CreativeWork
301 https://doi.org/10.2174/138920012798356952 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069176048
302 rdf:type schema:CreativeWork
303 https://doi.org/10.3109/03639045.2011.563781 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049089983
304 rdf:type schema:CreativeWork
305 https://www.grid.ac/institutes/grid.266871.c schema:alternateName University of North Texas Health Science Center
306 schema:name Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA
307 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...